| A comparative analysis of breast and ovarian cancer-related gene mutations in Canadian and Saudi Arabian patients with breast cancer Y Amemiya, S Bacopulos, M Al-Shawarby, D Al-Tamimi, W Naser, ... Anticancer Research 35 (5), 2601-2610, 2015 | 22 | 2015 |
| Novel KRAS gene mutations in sporadic colorectal cancer WM Naser, MA Shawarby, DM Al-Tamimi, A Seth, A Al-Quorain, ... PLoS One 9 (11), e113350, 2014 | 18 | 2014 |
| Towards a Process-Based and Service-Oriented Intelligent Framework for Ig/TCR Clonality Testing in Suspected Lymphoproliferative Neoplasms N Abdullah, Y Odeh, H Saadeh, A Iqniebi, A Hassan, W Nasser, M Odeh, ... 2018 1st International Conference on Cancer Care Informatics (CCI), 165 - 179, 2018 | 3 | 2018 |
| A Rare Case of Nasal Sarcoma with BCOR Internal Tandem Duplication Showing Complete Pathologic Response to the VDC-IE Chemotherapy Protocol S Salah, MA Sughayer, O Jaber, N Abu Abed, F Ajlouni, W Al Gargaz, ... Case Reports in Oncological Medicine 2023, 2023 | | 2023 |
| Endometrial carcinoma with multiple metastases to the central nervous system: a case report with a comparative NGS analysis of the primary and metastatic tumours M Al-Hussaini, A Tbakhi, W Naser, JZ Amarin, A Abi-Sheikha VIRCHOWS ARCHIV 481 (SUPPL 1), S260-S260, 2022 | | 2022 |
| A Rare Autosomal Dominant β-Thalassemia due to a Novel de novo Null HBB Gene Variant: Hb-Jordan W Naser, A Tbakhi, M Taha, N Kamal, R Abu Aboud, R Abu Khashabah, ... AMP 2022 Annual Meeting & Expo 24 (10), 29, 2022 | | 2022 |
| MGMT Promoter Methylation and IDH1 Mutation Testing to Prognosticate Glioblastoma Multiforme and Determine Alkylating Agent Treatment Eligibility: KHCC Experience W Naser, BE Muhsen, M Al-Hussaini, R Abu Aboud, M Al Masri, R Amarin, ... AMP 2022 Annual Meeting & Expo 24 (10), 131-132, 2022 | | 2022 |
| The O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status and clinical outcomes of Ewing sarcoma patients treated with irinotecan and temozolomide S Salah, W Naser, O Jaber, Y Saleh, R Mustafa, R Abuhijlih, F Abuhijla, ... reports of practical Oncology and radiotherapy 27 (5), 759-767, 2022 | | 2022 |
| The MGMT (O6-methylguanine–DNA methyltransferase) promotes methylation and clinical outcomes of salvage temozolomide and irinotecan chemotherapy in progressive Ewing sarcoma: A … S Salah, W Naser, O Jaber, yacob saleh, RMM Mustafa, R Abuhijlih, ... Journal of Clinical Oncology 39 (15_suppl), e23507-e23507, 2021 | | 2021 |
| Bifocal, anaplastic cerebellar liponeurocytoma with ABL1-L292M mutation MAA Erashdi, A Tbakhi, Y Al-Othman, W Naser, M Al-Hussaini VIRCHOWS ARCHIV 477, S108-S108, 2020 | | 2020 |
| Optimization and Validation of a Sanger Sequencing Clinical Assay for Germline BRCA1/2 Gene Mutation Detection at King Hussein Cancer Center W Naser, H Abdel-Razeq, L Abu Jamous, A Tbakhi The Journal of Molecular Diagnostics 22 (11), 1040–1056, 2020 | | 2020 |
| A Pipeline for Variant Calling in Tumor Panels Using Amplicon Sequencing Data A Al-okaily, N Abdullah, O Alsmadi, W Naser, F Alul, A Tbakhi 2018 1st International Conference on Cancer Care Informatics (CCI), 48-52, 2018 | | 2018 |
| In cis Heterozygous BRCA2 Pathogenic Mutations in a Jordanian Family: Case Report L Abu Jamous, WM Naser, R Abu-Obeid, O Alsmadi, N Abdullah, F Alul, ... JOURNAL OF MOLECULAR DIAGNOSTICS 20 (6), 910-910, 2018 | | 2018 |
| ANALYSIS OF BREAST AND OVARIAN CANCER RELATED GENE MUTATIONS IN CANADIAN AND SAUDI ARABIAN BREAST CANCER PATIENTS Y Amemiya, S Bacopulos, E Slodkowska, M Al-Shawarby, D Al-Tamimi, ... ANTICANCER RESEARCH 34 (10), 6160-6160, 2014 | | 2014 |
| Novel KRAS gene mutations in Saudi colorectal cancer patients WM Naser, MA Shawarby, DM Al-Tamimi, A Seth, A Al-Quorain, ... Pathology 46, S115-S116, 2014 | | 2014 |
| Poster# 31 W Naser, M Shawarby, D Al-Tamimi, A Seth, AA Al-Quorain, A Al-Nemr, ... | | |
| MOLECULAR GENETICS OF BREAST CANCER Y Amemiya, S Bacopulos, M Akbari, M Al-Shawarby, D Al-Tamimi, ... | | |
Dalal Al TamimiUniversity of DammamVerified email at uod.edu.sa
